Publication | Closed Access
CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
218
Citations
35
References
2015
Year
Our findings shed new light on the mechanisms underlying the progression of ER(+) breast cancer and indicate the potential of novel therapies targeting CCL2 and CCL5 pathways.
| Year | Citations | |
|---|---|---|
Page 1
Page 1